<DOC>
	<DOCNO>NCT00775658</DOCNO>
	<brief_summary>Use olopatadine ophthalmic solution ( eye drop ) decrease allergy skin test reactivity .</brief_summary>
	<brief_title>Olopatadine Eye Drops Allergy Skin Testing</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Adults age 18 75 year Healthy volunteer ( major illness active symptom ) Known allergy hypersensitivity drug component Pregnant nursing woman Women wish become pregnant study 's duration Use topical oral medication antihistaminic activity 14 day proceed randomization Dermatographism evidence skin test visit 1 Chronic urticaria active within past 6 month Severe hypertension Psychiatric diagnosis could potentially affect medication compliance , schizophrenia delusional disorder , determine investigator obtain inform consent base subject 's past medical history Inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>allergy</keyword>
	<keyword>skin test</keyword>
	<keyword>eye drop</keyword>
	<keyword>antihistamine</keyword>
</DOC>